Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects

NCT06000423 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT06000423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06000423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects
Lead sponsor
Oregon Health and Science University
Phase
Phase 4
Overall status
Completed
Start date
January 23, 2024
Completion date
August 14, 2025
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, contraceptive device; complications